Srinivas Veerla

3.3k total citations · 1 hit paper
48 papers, 2.3k citations indexed

About

Srinivas Veerla is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Srinivas Veerla has authored 48 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Srinivas Veerla's work include Epigenetics and DNA Methylation (11 papers), RNA modifications and cancer (7 papers) and Cancer-related Molecular Pathways (6 papers). Srinivas Veerla is often cited by papers focused on Epigenetics and DNA Methylation (11 papers), RNA modifications and cancer (7 papers) and Cancer-related Molecular Pathways (6 papers). Srinivas Veerla collaborates with scholars based in Sweden, Denmark and Spain. Srinivas Veerla's co-authors include Mattias Höglund, David Lindgren, Fredrik Liedberg, Gunilla Chebil, Sigurður Guðjónsson, Wiking Månsson, Gottfrid Sjödahl, Markus Ringnér, Mattias Aine and Mårten Fernö and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Srinivas Veerla

48 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Molecular Taxonomy for Urothelial Carcinoma

2012 637 citations Gottfrid Sjödahl, Martin Lauss et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Srinivas Veerla

Since Specialization

Citations

This map shows the geographic impact of Srinivas Veerla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srinivas Veerla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srinivas Veerla more than expected).

Fields of papers citing papers by Srinivas Veerla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srinivas Veerla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srinivas Veerla. The network helps show where Srinivas Veerla may publish in the future.

Co-authorship network of co-authors of Srinivas Veerla

This figure shows the co-authorship network connecting the top 25 collaborators of Srinivas Veerla. A scholar is included among the top collaborators of Srinivas Veerla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srinivas Veerla. Srinivas Veerla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Global Transcriptional Complexity of Estrogen Receptor–Low Positive Breast Cancers in the Prospective Swedish Population–Based SCAN-B Cohort 2025 ·Clinical Cancer Research ·Siker Kimbung, Srinivas Veerla, (unknown), Anna Ehinger, Johan Vallon‐Christersson, Martin Malmberg, Niklas Loman	1
2	Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters 2025 ·Cancer Immunology Immunotherapy ·Sofia Westbom-Fremer, Lena Tran, (unknown), (unknown), (unknown), Päivi Kannisto, Srinivas Veerla, Ingrid Hedenfalk	2
3	The role of extracellular vesicle fusion with target cells in triggering systemic inflammation 2024 ·Nature Communications ·Praveen Papareddy, (unknown), (unknown), Ravi K. V. Bhongir, Milladur Rahman, Maria Baumgarten, (unknown), (unknown), Emanuel Smeds, Ariane Neumann, Srinivas Veerla, (unknown), (unknown), Cécilia Rydèn, (unknown), Michal Holub, Heiko Herwald	20
4	A Versatile and Upgraded Version of the LundTax Classification Algorithm Applied to Independent Cohorts 2024 ·Journal of Molecular Diagnostics ·(unknown), Carina Bernardo, Srinivas Veerla, Fredrik Liedberg, Gottfrid Sjödahl, (unknown)	3
5	Kataegis in clinical and molecular subgroups of primary breast cancer 2024 ·npj Breast Cancer ·Srinivas Veerla, Johan Staaf	2
6	A human antithrombin isoform dampens inflammatory responses and protects from organ damage during bacterial infection 2019 ·Nature Microbiology ·Praveen Papareddy, (unknown), (unknown), (unknown), Srinivas Veerla, Clément Naudin, Emanuel Smeds, Johannes Westman, Irene Martínez‐Martínez, Arne Egesten, María Eugenia de la Morena‐Barrio, Javier Corral, Adam Linder, Andrea Artoni, Maria Abbattista, Cristina Novembrino, Cord Brakebusch, Ida Martinelli, Gopinath Kasetty, Heiko Herwald	21
7	Promoter-associated proteins of EPAS1 identified by enChIP-MS – A putative role of HDX as a negative regulator 2018 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Kristoffer von Stedingk, Toshitsugu Fujita, C. Persson, Pontus Eriksson, Srinivas Veerla, Katleen De Preter, Frank Speleman, Hodaka Fujii, Sven Påhlman, Sofie Mohlin	11
8	CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients 2016 ·BMC Cancer ·Maria Simonsson, Srinivas Veerla, Andrea Markkula, Carsten Rose, Christian Ingvar, Helena Jernström	12
9	Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis–Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer 2015 ·Clinical Cancer Research ·Siker Kimbung, Ida Johansson, Anna Danielsson, Srinivas Veerla, Søren Brage, Marianne Frostvik Stolt, Lambert Skoog, Lena Carlsson, Zakaria Einbeigi, Elisabet Lidbrink, Barbro Linderholm, Niklas Loman, Per-Olof Malmström, Martin Söderberg, Thomas Walz, Mårten Fernö, Thomas Hatschek, Ingrid Hedenfalk	36
10	Global Transcriptional Changes Following Statin Treatment in Breast Cancer 2015 ·Clinical Cancer Research ·Olöf Bjarnadottir, Siker Kimbung, Ida Johansson, Srinivas Veerla, Mats Jönsson, Pär‐Ola Bendahl, Dorthe Grabau, Ingrid Hedenfalk, Signe Borgquist	45
11	Identification of Transcriptional Subgroups in EGFR -Mutated and EGFR / KRAS Wild-Type Lung Adenocarcinoma Reveals Gene Signatures Associated with Patient Outcome 2013 ·Clinical Cancer Research ·Maria Planck, Sofi Isaksson, Srinivas Veerla, Johan Staaf	20
12	Prognostic Significance in Breast Cancer of a Gene Signature Capturing Stromal PDGF Signaling 2013 ·American Journal Of Pathology ·Oliver Frings, Martin Augsten, Nicholas P. Tobin, Joseph W. Carlson, Janna Paulsson, Cristina Peña, Eleonor Olsson, Srinivas Veerla, Jonas Bergh, Arne Östman, Erik L. L. Sonnhammer	49
13	Distinct Gene Expression Signatures in Lynch Syndrome and Familial Colorectal Cancer Type X 2013 ·PLoS ONE ·Mev Dominguez–Valentin, Christina Therkildsen, Srinivas Veerla, Mats Jönsson, Inge Bernstein, Åke Borg, Mef Nilbert	28
14	Constitutional trisomy 8 mosaicism as a model for epigenetic studies of aneuploidy 2013 ·Epigenetics & Chromatin ·Josef Davidsson, Srinivas Veerla, Bertil Johansson	19
15	STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer 2012 ·Cancer Research ·Cristina Peña, María Virtudes Céspedes, Maja Bradic Lindh, Sara Kiflemariam, Artur Mezheyeuski, Per‐Henrik Edqvist, Christina Hägglöf, Helgi Birgisson, Linda Bojmar, Karin Jirström, Per Sandström, Eleonor Olsson, Srinivas Veerla, Alberto Gallardo, Tobias Sjöblom, Andy Chang, Roger R. Reddel, Ramón Mangues, Martin Augsten, Arne Östman	145
16	A Molecular Taxonomy for Urothelial Carcinoma breakdown → 2012 ·Clinical Cancer Research ·Gottfrid Sjödahl, Martin Lauss, Kristina Lövgren, Gunilla Chebil, Sigurður Guðjónsson, Srinivas Veerla, Oliver Patschan, Mattias Aine, Mårten Fernö, Markus Ringnér, Wiking Månsson, Fredrik Liedberg, David Lindgren, Mattias Höglund	637
17	FUS-CREB3L2 / L1 –Positive Sarcomas Show a Specific Gene Expression Profile with Upregulation of CD24 and FOXL1 2011 ·Clinical Cancer Research ·Emely Möller, Jason L. Hornick, Linda Magnusson, Srinivas Veerla, Henryk A. Domanski, Fredrik Mertens	64
18	Combined Gene Expression and Genomic Profiling Define Two Intrinsic Molecular Subtypes of Urothelial Carcinoma and Gene Signatures for Molecular Grading and Outcome 2010 ·Cancer Research ·David Lindgren, Attila Frigyesi, Sigurður Guðjónsson, Gottfrid Sjödahl, Christer Halldén, Gunilla Chebil, Srinivas Veerla, Tobias Rydèn, Wiking Månsson, Fredrik Liedberg, Mattias Höglund	224
19	The DNA methylome of pediatric acute lymphoblastic leukemia 2009 ·Human Molecular Genetics ·Josef Davidsson, Henrik Lilljebjörn, Anna Andersson, Srinivas Veerla, Jesper Heldrup, Mikael Behrendtz, Thoas Fioretos, Bertil Johansson	64
20	Promoter analysis of epigenetically controlled genes in bladder cancer 2008 ·Genes Chromosomes and Cancer ·Srinivas Veerla, Ioannis Panagopoulos, Yuesheng Jin, David Lindgren, Mattias Höglund	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact